Chapter 308

At 10 a.m. on June 6, 2022, universal biology held a grand press conference in Jiangzhou International Conference Center.

In the past year or so, universal biology has held a press conference every now and then, and each time is a major medical breakthrough or technological innovation.

Because of this, as soon as the news was released, countless journalists from home and abroad flocked to the site, and thousands of reporters occupied the huge publishing hall.

Lin Wei, vice president and chief press officer, presided over the press conference.

Under the attention of numerous reporters, Lin Wei said with excitement: "good morning, ladies and gentlemen, ladies and gentlemen, welcome to the world's press conference..."

Click, click, click!!!

In the interval between Lin Wei's speech, the release hall instantly became an ocean of magnesium lamps.

Lin Wei stopped for a moment and then said: "here I want to tell you a piece of good news. Under the leadership of Zhou Wen, chief scientist of global biology, Lin Ming, senior engineer, he Junfeng, deputy director and chief scientist of hepatitis B Research Institute of Chinese Academy of Sciences, as well as the continuous efforts of hundreds of other researchers, we have successfully conquered hepatitis B! ”

the scene of the press conference was a little quiet at first, but the next second, there was a huge buzz.

What do you mean, a new drug

"I still don't understand. Conquering is healing."

"It's impossible. Hepatitis B virus can't be cured."

"Then I don't know..."

Lin Wei gave reporters more than ten seconds to digest what he had just said, and then explained their research results.

When the reporter on the spot learned that this drug will cure nearly 300 million hepatitis B patients around the world, a heated discussion broke out.

……

The news that hepatitis B virus has been conquered has spread all over the world in an instant.

Innumerable hepatitis B patients see this news, nature is extremely excited.

However, some pharmaceutical companies that are studying new hepatitis B drugs and have even reached the stage of clinical trials are suddenly struck by lightning after hearing the news.

In particular, the six pharmaceutical companies that got the data of universal bio formula spent so much energy on it, but they all failed in the end.

……

Kyoto inner ring, a building with national emblem.

A Chinese face man was reading an internal reference news, and soon read the news.

With a slightly surprised look on his face, he asked in a deep voice, "is this news true?"

The confidential secretary who was sorting out the information immediately said respectfully: "yes, chief, the experts from the food and drug administration have detected it with DGD technology, which is absolutely true."

The Chinese character face man nodded, and a smile appeared on his serious face. He said with a smile: "no wonder you dare to promise me. It seems that you have been prepared for it."

The confidential secretary said with a smile: "yes! Professor Zhou's level in the field of medicine is really worthy of the word "miracle doctor."

It is self-evident how important DGD technology is for pharmaceutical enterprises. It can be regarded as one of the greatest inventions in the pharmaceutical industry. Such high-end technology can not be disclosed by universal biology if it wants to be disclosed. It must be approved by the national level.

The same is true for European and American countries. The technology of European and American enterprises is not readily exported to China.

Therefore, it can be imagined that when universal biology proposed DGD technology sharing, how fierce opposition was encountered?

Many of the top leaders who trusted Zhou Wen were also opposed.

But Zhou Wen still convinced a group of big men.

Zhou Wen's reason is very good. Although DGD technology is important, it is far from enough to rely on a DGD technology to regain the standard of global pharmaceutical market.

First of all, nmpa has always followed the FDA's lead, and Rome wasn't built in a day. It's not a day or two to completely reverse this situation.

Because it involves a lot of interests.

There are disputes when there are interests. Many people are not willing to leave the comfort zone to explore unknown areas. If they do well, they are the leaders. If they do not do well or make mistakes, the specific operators will have bad luck. Therefore, the promotion of DGD technology in China has encountered great resistance.

Secondly and most importantly, European and American countries will certainly not allow DGD technologies mastered by Chinese enterprises to implement in their own countries, even if supported by the academic community and advocated by pharmaceutical enterprises.

Don't even think about it.

Then the problem comes. Even if China's nmpa adopts the DGD technical standard, the drugs developed by Huanqiu biology need to go through a time-consuming and lengthy clinical trial procedure if they want to be sold abroad.

Some people may have to say that it is their business that European and American countries are willing to be complacent. It is better to sell them at home.

However, Zhou Wen can't wait. His new drug research and development speed is far faster than most people think. He has a large number of new drugs in his hand and needs to be put into the market. However, the long time of clinical trials has led to the failure of the drugs to go on the market as quickly as the cosmetics and hair tonics, scar removing cream and wrinkle removing cream.And DGD technology is a stepping stone to the European and American pharmaceutical market.

At the speed of Zhou Wen's drug research and development, European and American pharmaceutical companies together are not enough for him.

Therefore, sharing DGD technology with Europe and the United States is not convenient for European and American countries, but for their own convenience.

Of course, these ordinary people don't know.

The reason why the top leaders agreed to Zhou Wen was because of his medical skills.

Zhou Wen's medical skills have almost reached the point of perfection. The master of Chinese medicine is not enough to describe him. The big men and his family members now call him "miracle doctor".

Can you imagine the weight of his words?

Therefore, when he patted his chest and assured the leaders that they would make profits from DGD technology, they finally agreed to his proposal.

Now it seems that Zhou Wen has already prepared his mace!

……

……

Half a month later.

The "Qingganling preparation" code named pd0079 developed by Huanyu biology, as well as the class II new drugs of other four or five pharmaceutical enterprises, have become the first batch of experimental objects of DGD technology in China, and the first phase of clinical trial has been carried out.

It usually takes 3 to 6 months for a clinical trial. After using DGD technology, the trial was completed in only one week.

Of course, "Qingganling preparation" passed the first phase of clinical trial without accident.

As soon as the news came out, it immediately caused a great sensation.

Numerous pharmaceutical laboratories and pharmaceutical companies were surprised and envied by the efficiency and speed of DGD technology.

The relevant departments in Europe, America, Japan and South Korea have also accelerated the approval of DGD technology.

Soon, Wuhan became the second country to adopt DGD technology.

Japan benzene followed closely.

Then Germany, Portugal, France, Italy, Russia

At the same speed as competition, "Qingganling preparation" has passed the second phase of clinical trial.

Everything is ready to go

www.novelhold.com , the fastest update of the webnovel!